Project/Area Number |
09670846
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | Kanazawa Medical University |
Principal Investigator |
SHINKA Toshihiro Medical Research Institute, Kanazawa Medical University, Associate Professor, 総合医学研究所, 助教授 (10098858)
|
Project Period (FY) |
1997 – 1998
|
Project Status |
Completed (Fiscal Year 1998)
|
Budget Amount *help |
¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 1998: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1997: ¥1,100,000 (Direct Cost: ¥1,100,000)
|
Keywords | neonatal mass screening / gas chromatography / mass spectrometry (GC / MS) / galactosemia / galactosuria / heterozygote / urease / chemical diagnosis / ウレアーゼ |
Research Abstract |
We determined urinary galactose and 4-hydroxyphenyllactic acid in 4,338 of 5-day-old newborns using a newly developed GC/MS screening method. Fifty-two infants were chemically diagnosed as having transient galactosuria based upon elevated urinary galactose levels (4.78-30.53mg/mg creatinine, control 1.10±0.89mg/mg creatinine). These infants did not excrete galactitol or galactonic acid into the urine, which is typical of hereditary galactosemia. Nearly 40% of the transient galactosuria was associated with immature infants (low birth weight or borne before 37 gestational weeks). Immature hepatic function is one explanation for neonatal transient galactosuria, but heterozygotes or the carriers of galactose degradation enzyme deficiencies were also suspected in some of the newborns, judging from the comparisons of urinary galactose and 4HPLA excretion between neonates and patients with galactosemia.
|